Ramos CG - Search Results

1

PCA3 sensitivity and specificity for prostate cancer detection in patients with abnormal PSA and/or suspicious digital rectal examination. First Latin American experience.

Ramos CG, Valdevenito R, Vergara I, Anabalon P, Sanchez C, Fulla J. Ramos CG, et al. Urol Oncol. 2013 Nov;31(8):1522-6. doi: 10.1016/j.urolonc.2012.05.002. Epub 2012 Jun 9. Urol Oncol. 2013. PMID: 22687565

2

Laparoscopic partial nephrectomy: A series of one hundred cases performed by the same surgeon.

Campero JM, Ramos CG, Valdevenito R, Mercado A, Fullá J. Campero JM, et al. Among authors: ramos cg. Urol Ann. 2012 Sep;4(3):162-5. doi: 10.4103/0974-7796.102664. Urol Ann. 2012. PMID: 23248523 Free PMC article.

3

Exosomes from bulk and stem cells from human prostate cancer have a differential microRNA content that contributes cooperatively over local and pre-metastatic niche.

Sánchez CA, Andahur EI, Valenzuela R, Castellón EA, Fullá JA, Ramos CG, Triviño JC. Sánchez CA, et al. Among authors: ramos cg. Oncotarget. 2016 Jan 26;7(4):3993-4008. doi: 10.18632/oncotarget.6540. Oncotarget. 2016. PMID: 26675257 Free PMC article.

4

[Usefulness of imaging studies in prostate cancer: Analysis of 241 patients].

Martínez M N, Calvo C, Ibarra Á, Ramos C, Zambrano N. Martínez M N, et al. Rev Med Chil. 2017 May;145(5):579-584. doi: 10.4067/S0034-98872017000500004. Rev Med Chil. 2017. PMID: 28898333 Free article. Spanish.

5

Percent carcinoma in prostatectomy specimen is associated with risk of recurrence after radical prostatectomy in patients with pathologically organ confined prostate cancer.

Ramos CG, Roehl KA, Antenor JA, Humphrey PA, Catalona WJ. Ramos CG, et al. J Urol. 2004 Jul;172(1):137-40. doi: 10.1097/01.ju.0000132139.40964.75. J Urol. 2004. PMID: 15201754

6

Digital rectal examination for detecting prostate cancer at prostate specific antigen levels of 4 ng./ml. or less.

Carvalhal GF, Smith DS, Mager DE, Ramos C, Catalona WJ. Carvalhal GF, et al. J Urol. 1999 Mar;161(3):835-9. J Urol. 1999. PMID: 10022696

7

Prostate-specific antigen cutoff of 2.6 ng/mL for prostate cancer screening is associated with favorable pathologic tumor features.

Krumholtz JS, Carvalhal GF, Ramos CG, Smith DS, Thorson P, Yan Y, Humphrey PA, Roehl KA, Catalona WJ. Krumholtz JS, et al. Among authors: ramos cg. Urology. 2002 Sep;60(3):469-73; discussion 473-4. doi: 10.1016/s0090-4295(02)01875-7. Urology. 2002. PMID: 12350486

8

The effect of high grade prostatic intraepithelial neoplasia on serum total and percentage of free prostate specific antigen levels.

Ramos CG, Carvahal GF, Mager DE, Haberer B, Catalona WJ. Ramos CG, et al. J Urol. 1999 Nov;162(5):1587-90. J Urol. 1999. PMID: 10524873

9

Lowering PSA cutoffs to enhance detection of curable prostate cancer.

Catalona WJ, Ramos CG, Carvalhal GF, Yan Y. Catalona WJ, et al. Among authors: ramos cg. Urology. 2000 Jun;55(6):791-5. doi: 10.1016/s0090-4295(99)00602-0. Urology. 2000. PMID: 10840078 No abstract available.

10

Cancer progression and survival rates following anatomical radical retropubic prostatectomy in 3,478 consecutive patients: long-term results.

Roehl KA, Han M, Ramos CG, Antenor JA, Catalona WJ. Roehl KA, et al. Among authors: ramos cg. J Urol. 2004 Sep;172(3):910-4. doi: 10.1097/01.ju.0000134888.22332.bb. J Urol. 2004. PMID: 15310996

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

74 results

Search Page

Filters